Neogen (NEOG) | Financial Analysis & Statements

Neogen Corporation | Small-cap | Healthcare

$4.98

-6.57%

Neogen vs Thermo Fisher Neogen vs Danaher Neogen vs Twist Bioscience Neogen vs Grail Neogen vs Opko Health Neogen vs S&P 500 | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 924.2M

Gross Profit 463.9M 50.19%

Operating Income 58.7M 6.35%

Net Income -9.4M -1.02%

EPS (Diluted) -$0.04

Balance Sheet Metrics

Total Assets 4.5B

Total Liabilities 1.4B

Shareholders Equity 3.1B

Debt to Equity 0.45

Cash Flow Metrics

Operating Cash Flow 23.2M

Free Cash Flow -76.2M

Revenue & Profitability Trend

Neogen Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue	924.2M	822.4M	527.2M	468.5M	418.2M
Cost of Goods Sold	460.3M	416.5M	284.1M	253.4M	221.9M
Gross Profit	463.9M	406.0M	243.0M	215.1M	196.3M
Operating Expenses	405.2M	368.4M	184.4M	140.9M	128.8M
Operating Income	58.7M	37.5M	58.6M	74.2M	67.5M
Pre-tax Income	-14.3M	-22.0M	60.2M	75.3M	72.3M
Income Tax	-4.9M	828.0K	11.9M	14.4M	12.8M
Net Income	-9.4M	-22.9M	48.3M	60.9M	59.5M
EPS (Diluted)	-$0.04	-$0.12	$0.45	$0.57	$0.56

Income Statement Trend

Neogen Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	589.2M	585.9M	626.8M	591.5M	537.4M
Non-Current Assets	4.0B	4.0B	366.1M	328.7M	259.8M
Total Assets	4.5B	4.6B	992.9M	920.2M	797.2M
Liabilities
Current Liabilities	154.3M	145.5M	77.8M	53.6M	48.5M
Non-Current Liabilities	1.3B	1.3B	27.7M	26.2M	23.5M
Total Liabilities	1.4B	1.4B	105.6M	79.8M	72.0M
Equity
Total Shareholders Equity	3.1B	3.1B	887.4M	840.4M	725.2M

Balance Sheet Composition

Neogen Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income	-9.4M	-22.9M	48.3M	60.9M	59.5M
Operating Cash Flow	23.2M	40.6M	72.1M	84.5M	79.8M
Investing Activities
Capital Expenditures	-111.3M	-64.9M	-24.4M	-26.7M	-24.1M
Investing Cash Flow	-29.3M	201.0M	-97.2M	-105.6M	-88.8M
Financing Activities
Dividends Paid	-	-	-	-	-
Financing Cash Flow	-538.0K	-119.3M	-1.1M	-1.1M	0
Free Cash Flow	-76.2M	-24.7M	43.6M	54.4M	61.8M

Cash Flow Trend

Neogen Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 865.00

Forward P/E 8.08

Price to Book 0.39

Price to Sales 1.14

PEG Ratio 8.08

Profitability Ratios

Profit Margin -53.56%

Operating Margin 2.45%

Return on Equity -16.71%

Return on Assets 0.59%

Financial Health

Current Ratio 3.91

Debt to Equity 33.61

Beta 1.84

Per Share Data

EPS (TTM) -$2.23

Book Value per Share $12.26

Revenue per Share $4.18

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
neog	1.0B	865.00	0.39	-16.71%	-53.56%	33.61
Thermo Fisher	152.5B	23.69	3.09	13.70%	15.19%	69.23
Danaher	140.5B	37.98	2.76	7.22%	15.81%	34.56
Twist Bioscience	2.2B	-9.85	4.89	-38.22%	-54.98%	18.25
Grail	1.5B	-0.70	0.61	-62.22%	-62.12%	2.67
Opko Health	1.0B	-16.12	0.65	-3.04%	-5.66%	37.58

Financial data is updated regularly. All figures are in the company's reporting currency.